Information and communication technology in patient education and support for people with schizophrenia

Cochrane Database of Systematic Reviews

Volumn 2012, Issue 10, 2012, Pages

  Välimäki, Maritta ^a   Hätönen, Heli ^a   Lahti, Mari ^a   Kuosmanen, Lauri ^a   Adams, Clive E ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b INSTITUTE OF MENTAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL INFORMATICS; META ANALYSIS; METHODOLOGY; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA;

COMMUNICATION; HUMANS; MEDICAL INFORMATICS APPLICATIONS; PATIENT EDUCATION AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA;

EID: 84871869359     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007198.pub2     Document Type: Review

References (125)

1. Chen L-S, Li Z-G, Chen Y-F, Xiao C-L, Huang J-J, Bao G-L, et al. Comparative study of relapse prevention in schizophrenia by network [利用网络防治精神分裂症复发对照研究]. Linchuang Jingshen Yixue Zazhi [临床精神医学杂志] 2007;17(4):234-6.
2. Bylund C. Structured patient-clinician communication using DIALOG improves patient quality of life. Evidence-Based Mental Health 2008;11(3):89.
3. Hansson L, Svensson B, Bjorkman T, Bullenkamp J, Lauber C, Martinez-Leal R, et al. What works for whom in a computer-mediated communication intervention in community psychiatry? Moderators of outcome in a cluster randomized trial. Acta Psychiatrica Scandinavica 2008;118(5):404-9.
4. Priebe S, McCabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, et al. Structured patient-clinician communication and 1-year outcome in community mental healthcare: cluster randomised controlled trial. British Journal of Psychiatry 2007;191:420-6. [MEDLINE: 17978322]
5. Jones R. Development and evaluation of personalised patient information for patients with schizophrenia living in the community. Current Controlled Trials 2004.
6. Jones R. Development and evaluation of personalised patient information for patients with schizophrenia living in the community. National Research Register 2000. [National Research Register N0466011493]
7. Jones R. Development and evaluation of personalised patient information for patients with schizophrenia living in the community. National Research Register 2001; Vol. 1. [N0466011493]
8. Jones RB, Atkinson JM, Coia DA, Paterson L, Morton AR, McKenna K, et al. Randomised trial of personalised computer based information for patients with schizophrenia. BMJ 2001;322(7290):835-40. [MEDLINE: 11290639]
9. Rotondi AJ. Schizophrenia patient and family continuity of care. http://www.clinicaltrials.gov 2003. [NCT00051233]
10. Rotondi AJ. Support to patients and families. http://www.clinicaltrials.gov 2005. [NCT00177983]
11. Rotondi AJ, Haas G, Anderson C, Ganguli R, Keshavan M, Newhill C, et al. A randomized trial of a telehealth intervention to provide in-home psychoeducation to persons with schizophrenia and their families: intervention design and preliminary findings. Schizophrenia Bulletin 2005;31(2):533.
12. Rotondi AJ, Haas GL, Anderson CM, Newhill CE, Spring MB, Ganguli R, et al. A clinical trial to test the feasibility of a telehealth psychoeducational intervention for persons with schizophrenia and their families: intervention and 3-month findings. Rehabilitation Psychology 2005;50(4):325-36. [AMED: 0081778; CINAHL: 2009074611]
13. Salzer MS, Tunner T, Charney NJ. A low-cost, telephone intervention to enhance schizophrenia treatment: a demonstration study. Schizophrenia Research 2004;66(1):75-6. [EMBASE: 2004010745]
14. Kuosmanen L, Valimaki M, Joffe G, Pitkanen A, Hatonen H, Patel A, et al. The effectiveness of technology-based patient education on self-reported deprivation of liberty among people with severe mental illness: a randomized controlled trial. Nordic Journal of Psychiatry 2009;63(5):383-9.
15. Valimaki M. Information technology in mental health. http://www.controlled-trials.com 2010.
16. Berns S. Electronic assistive device to help patients with schizophrenia. National Alliance for Research on Schizophrenia and Depression (http://www.mhsource.com/narsad/bd/studyops.html) (accessed February 2001).
17. Borell P, Orhagen T, D'Elia G. Feasibility and effects of a patient information program in schizophrenia [Sjukdomsrelaterad information vid schizofreni: klinisk tillämpning och effekter]. Scandinavian Journal of Behaviour Therapy 1995;24(3-4):75-86. [PSYCINFO: 1996-18099-002]
18. Burgoyne RW, Acosta FX, Yamamoto J. Telephone prompting to increase attendance at a psychiatric outpatient clinic. American Journal of Psychiatry 1983;140:345-7. [MEDLINE: 6829808]
19. Cramer JA, Rosenheck R. Enhancing medication compliance for people with serious mental illness. Journal of Nervous and Mental Disease 1999;187(1):53-5. [MEDLINE: 9952254]
20. Crespo Iglesias JM, Gonzalez Garcia A, Santos Miguelez B, Naya Fernandez S. Improvement of the attendance to the first psychiatric appointments after telephone reminder [Mejoria de la asistencia a las primeras citas en psiquiatria tras aviso telefonico]. Anales de Psiquiatria 2006;22(3):95-101. [MEDLINE: 1254142]
21. Fan X-H. The effects of community nursing intervention on the recovery of patients with primary schizophrenia. Journal of the Linyi Medical College 2005;27(6):419-21.
22. Frangou S. Remote home monitoring of patients. National Research Register 2001; Vol. 3. [N0042099581]
23. Frangou S. Remote home monitoring of patients. National Research Register 2002; Vol. 1. [N0042099581]
24. Frangou S, Sachpazidis I, Stassinakis A, Sakas G. Telemonitoring of medication adherence in patients with schizophrenia. Telemedicine Journal and E-Health 2005;11(6):675-83. [MEDLINE: 16430387]
25. Han DH, Renshaw PF, Sim ME, Kim JI, Arenella LS, Lyoo IK. The effect of internet video game play on clinical and extrapyramidal symptoms in patients with schizophrenia. Schizophrenia Research 2008;103(1-3):338-40.
26. Janssen B, Ludwig S, Eustermann H, Menke R, Haerter M, Berger M, et al. Improving outpatient treatment in schizophrenia: effects of computerised guideline implementation--results of a multicenter-study within the German research network on schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 2010;260(1):51-7. [MEDLINE: 19876665]
27. Kluger MP, Karras A. Strategies for reducing missed initial appointments in a community mental health center. Community Mental Health Journal 1983;19(2):137-43. [MEDLINE: 84083196; 6653081]
28. Kopelowicz A, Liberman RP, Wallace CJ, Aguirre F, Mintz J. Differential performance of job skills in schizophrenia: an experimental analysis. Journal of Rehabilitation 2006;72(4):31-9.
29. MacDonald J. Telephone prompting improves attendance at community mental health centres - provided the phone is answered. Unpublished report 1994. [MEDLINE: 16430387]
30. MacDonald J, Brown N, Ellis P. Using telephone prompts to improve initial attendance at a community mental health centre. Psychiatric Services 2000;51(6):812-4. [MEDLINE: 92335471]
31. Montes J, Saiz Ruiz J, Claret J, Maurino J, Diez T. Effect of a nurse telephone follow-up on therapeutic adherence of patients with schizophrenia. World Psychiatry 2009;8(Suppl 1):274-81. [MEDLINE: 19223439]
32. Park KM, Ku J, Park IH, Park JY, Kim SI, Kim JJ. Improvement in social competence in patients with schizophrenia: a pilot study using a performance-based measure using virtual reality. Human Psychopharmacology - Clinical and Experimental 2009;24(8):619-27. [MEDLINE: 19946937]
33. Pijnenborg GHM, Withaar FK, Brouwer WH, Timmerman ME, van den Bosch RJ, Evans JJ. The efficacy of SMS text messages to compensate for the effects of cognitive impairments in schizophrenia. British Journal of Clinical Psychology 2010;49:259-74. [MEDLINE: ISI:000277062000008]
34. Rossi, E. Effects of a simple strategy on attendance and satisfaction with medication clinic services in the chronically mentally ill [PhD thesis]. United States International University, USA, 1994.
35. Shon KH, Park SS. Medication and symptom management education program for the rehabilitation of psychiatric patients in Korea: the effects of promoting schedule on self-efficacy theory. Yonsei Medical Journal 2002;43(5):579-89.
36. Yi L-F, Zhu S-Y. Interventional effect of regular psychological therapy on the improvement of schizophrenia accompanied by depressive mood in the community: one-year follow-up. Chinese Journal of Clinical Rehabilitation [Zhongguo lin chuang kang fu] 2006;10(22):18-20.
37. Hulsbosch AM, Kroon H. Randomised controlled trial of home automation in mental health. http://www.trialregister.nl/trialreg/index.asp 2008.
38. Jahn T. Cognitive determinants of psychoeducation and information in psychoses. http://www.clinicaltrials.gov 2008.
39. Potts W, Kreyenbuhl JA. A patient-centered approach to improve screening for side effects of second generation antipsychotics (SGAs). http://www.clinicaltrials.gov 2008.
40. Eli Lilly Prague Psychiatric Center. Study with information technology (IT) - aided preventive program in schizophrenia. http://www.clinicaltrials.gov 2008.
41. Weisbrod M, Kaiser S. Complex problem solving training in schizophrenic patients. http://www.clinicaltrials.gov 2007. [NCT00507988]
42. Young AS, Cohen AN, Oksas K. Web-based delivery of move! to veterans with serious mental illness (SMI). http://www.clinicaltrials.gov 2009.
43. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200.
44. American Psychiatric Association. Global assessment of functioning GAF. DSM IV - Diagnostic Statistical Manual. 4th Edition. American Psychiatric Association, 1994.
45. APA. DSM IV - Diagnostic Statistical Manual. 4th Edition. American Psychiatric Association, 1994.
46. Auquier P, Lancon C, Rouillon F, Lader M. Mortality in schizophrenia. Pharmacoepidemiology & Drug Safety 2007;16(12):1308-12.
47. Barrowclough C, Tarrier N, Watts S, Vaughn C, Bamrah JS, Freeman HL. Assessing the functional value of relatives' knowledge about schizophrenia: a preliminary report. British Journal of Psychiatry 1987;151:1-8.
48. Bland JM, Kerry SM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
49. Bobes J, Carcía-Portilla MP, Bascarán MT, Saíz PA, Bousoño M. Quality of life in schizophrenia patients. Dialogues in Clinical Neurosciences 2007;9:215-26.
50. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use. Therapie 1999;54(4):405-11.
51. Boyce N. The Lancet Technology. The Lancet 2011;378(9840):1691.
52. Chan S, Yu IW. Quality of life of clients with schizophrenia. Journal of Advanced Nursing 2004;45:72-83.
53. Chinese Society of Psychiatry. CCMD-3 – Chinese Classification of Mental Disorders. 3rd Edition. Chinese Society of Psychiatry, 2001.
54. Christensen H, Griffiths KM, Korten A. Web-based cognitive behavior therapy: analysis of site usage and changes in depression and anxiety scores. Journal of Medical Internet Research 2002;4(1):e3.
55. Cooper JE, Sartorius N. Mental Health Disorders in China: Results of the National Epidemiological Survey in 12 Areas. London: Gaskell, 1996.
56. David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. British Journal of Psychiatry 1992;161(5):599-602.
57. Deeks J. Issues in the selection for meta-analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa. 2000.
58. Divine GW, Brown JT, Frazer LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7:623-9.
59. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-80.
60. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629-34.
61. Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
62. European Commission 2001. Communication from the Commission to the Council and the European Parliament. Information and communication technologies in development. The role of ICTs in EU development policy. http://ec.europa.eu/development/icenter/repository/com2001_0770en01_en.pdf (assessed 7 July 2009).
63. European Commission. Action plan 2011 - 2015. http://ec.europa.eu/information_society/activities/egovernment/action_plan_2011_2015/index_en.htm (accessed 6 September 2011).
64. European Communities. eHealth priorities and strategies in European countries. http://ec.europa.eu/information_society/activities/health/docs/policy/ehealth-era-full-report.pdf (accessed 6 September 2011).
65. EuroQol Group. EQ-5D – Health Related Quality of Life Questionnaire. EuroQol, 1990.
66. Evans S, Banerjee S, Leese M, Huxley P. The impact of mental illness on quality of life: a comparison of severe mental illness, common mental disorder and healthy population samples. Quality of Life Research 2007;16:17-29.
67. Eysenbach G. What is eHealth?. Journal of Medical Internet Research 2001;3(2):e20.
68. Fischer CS. What do we mean by “friend”? An inductive study. Social Networks 1982;3:287–306.
69. Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. Journal of Clinical Psychiatry 2004;65(10):1372-6.
70. Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83.
71. Gumley A, Karatzias A, Power K, Reilly J, McNay L, O'Grady M. Early intervention for relapse in schizophrenia: impact of cognitive behavioural therapy on negative beliefs about psychosis and self-esteem. British Journal of Clinical Psychology 2006;45(2):247-60.
72. Guy W. Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology. Revised. Rockville, MD: National Institute of Mental Health, 1976:218-22.
73. Haro JM, Novick D, Suarez D, Alonso J, Lépine JP, Ratcliffe M. SOHO study group. Remission and relapse in the outpatient care of schizophrenia: three-year results from the schizophrenia outpatient health outcomes study. Journal of Clinical Psychopharmacology 2006;26(6):571-8.
74. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
75. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
76. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine 1983;13:177-83.
77. Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. Journal of Psychopharmacology 2010;24(Suppl 4):81-90.
78. Hu Y, Huang Y, Ding J, Liu Y, Fan D, Li T, et al. Status of clinical research in China. Lancet 2011;377:124-5.
79. International Telecommunication Union. Measuring the information society. The ICT development index. http://www.itu.int/net/pressoffice/backgrounders/general/pdf/5.pdf (accessed 6 September 2011).
80. Jadad A, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
81. Jones RB, Atkinson JM, Coia DA, Paterson L, Morton AR, McKenna K, et al. Randomised trial of personalised computer based information for patients with schizophrenia. BMJ 2001;322(7290):835-40.
82. Kaplan HI, Sadock BJ. Comprehensive Textbook of Psychiatry. Williams & Wilkins: Baltimore, MD, 1995.
83. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987;13(2):261-76.
84. Kikkert MJ, Schene AH, Koeter MWJ, Robson D, Born A, Helm H, et al. Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophrenia Bulletin 2006;32(4):786-94.
85. Kuosmanen L, Välimäki M, Joffe G, Pitkänen A, Hätönen H, Patel A, et al. The effectiveness of technology-based patient education on self-reported deprivation of liberty among people with severe mental illness: a randomised controlled trial. Nordic Journal of Psychiatry 2009;63:383-9.
86. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Evaluation and Program Planning 1979;2:197-207.
87. Leucht S, Engel RR, Bauml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin 2007;33(1):183-91. [PUBMED: 16905632]
88. Lewis D. Computers in patient education. CIN: Computers, Informatics, Nursing 2003;21(2):88-96.
89. Marshall M, Lockwood A, Adams C, Bradley C, Joy C, Fenton M. Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?. British Journal of Psychiatry 2000;176:249-52.
90. McAllister L, Fischer CS. A procedure for surveying personal networks. Sociological Methods & Research 1978;7:131-48.
91. McEvoy JP, Apperson LJ, Appelbaum PS, Ortlip P, Brecosky J, Hammill K, et al. Insight in schizophrenia. Its relationship to acute psychopathology. Journal of Nervous and Mental Disease 1989;177(1):43-7.
92. Ministerial declaration. http://europa.eu.int/information_society/eeurope/ehealth/conference/2003/doc/min_dec_22_may_03 (accessed 22 October 2010).
93. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trial. BMJ 2010;340:c869.
94. Morrison AP, French P, Lewis SW, Roberts M, Raja S, Neil ST, et al. Psychological factors in people at ultra-high risk of psychosis: comparisons with non-patients and associations with symptoms. Psychological Medicine 2006;36(10):1395-404.
95. Mueser K, McGurk S. Schizophrenia. Lancet 2005;363(9426):2063-72.
96. Murray E, Burns J, See TS, Lai R, Nazareth I. Interactive health communication applications for people with chronic disease. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD004274.pub4]
97. Oh H, Rizo C, Enkin M, Jadad A. What Is eHealth: a systematic review of published definitions. Journal of Medical Internet Research 2005;7(1):e1.
98. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports 1962;10:799-812.
99. Palmer B, Pankratz S, Bostwick JM. Lifetime risk of suicide in schizophrenia. Archives of General Psychiatry 2005;62:247-53.
100. Perkins DO, Stroup TS, Lieberman JA. Psychotic disorder measures. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association, 2000:485-90.
101. Perry A, Tarrier N, Morris R, McCarthy E, Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 1999;318:149-53.
102. Podoll K, Habermeyer E, Nöller B, Ebel H, Sas H. Internet as a delusional topic in paranoid schizophrenia [Internet als wahnthema bei paranoider schizophrenie]. Nervenarzt 2000;71:912-4.
103. Proudfoot J, Ryden C, Everitt B, Shapiro DA, Goldberg D, Mann A, et al. Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. British Journal of Psychiatry 2004;185:46-54.
104. Riper H, Andersson G, Christensen H, Cuijpers P, Lange A, Eysenbach G. Theme issue on e-mental health: a growing field in internet research. Journal of Medical Internet Research 2010;12(5):e74.
105. Shen Y, Wang C. A Handbook of Epidemiological Investigation of Mental Illness. Beijing: Renming Health Press, 1985.
106. Silber D. The case for eHealth. Proceedings of the European commission's conference on eHealth; 2003 May 22-23; Brussels. 2003.
107. Slade M, Leese M, Cahill S, Thornicroft G. Patient-rated mental health needs and quality of life improvement. British Journal of Psychiatry 2005;187:256-61.
108. Smith B, Fowler DG, Freeman D, Bebbington P, Bashforth H, Garety P, et al. Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations. Schizophrenia Research 2006;86(1-3):181-8.
109. Španiel F, Novák T, Motlová L, Hrdlička J, Höschl C. Information technology aided relapse prevention program in schizophrenia (ITAREPS): reliability and validity of the early warning signs questionnaire. Psychiatry 2007;11:157–9.
110. Suhonen R, Leino-Kilpi H, Välimäki M, Kim HS. The patient satisfaction scale - an empirical investigation into the Finnish adaptation. Journal of Evaluation in Clinical Practice 2007;13:31-8.
111. Tandon R, Targum SD, Nasrallah HA, Ross R. The treatment effectiveness in schizophrenia consortium institution. Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. Journal of Psychiatric Practice 2006;12(6):348-63.
112. Turkington D, Kingdon DG, Turner T. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry 2002;180:523-7.
113. Turner MS, Stewart DW. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. Journal of Psychopharmacology 2006;20(6):20-37.
114. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment 1999;3(5):iii-92.
115. Walker H. Computer-based education for patients with psychosis. Nursing Standard 2006;20(30):49-56.
116. Watson PW, Garety PA, Weinman J, Dunn G, Bebbington PE, Fowler D, et al. Emotional dysfunction in schizophrenia spectrum psychosis: the role of illness perceptions. Psychological Medicine 2006;36(6):761-70.
117. World Health Organization. ICD 10 - International Statistical Classification of Diseases and Related Health Problems. WHO, 1992.
118. World Health Organization. Schizophrenia. http://www.who.int (assessed 24 August 2009).
119. World Health Organization. Schizophrenia. http://www.who.int/mental_health/management/schizophrenia/en/ (accessed August 2011).
120. Wing JK, Beevor AS, Curtis RH. Health of the nation outcome scales (Ho NOS). Research and development. British Journal of Psychiatry 1998;172:11-8.
121. Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized?. Trials 2009;10:46. [PUBMED: 19573242]
122. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al. The Leeds outcomes stakeholders survey (LOSS) study. Proceedings of the 15th Cochrane Colloquium; 2007 Oct 23-27; Sao Paulo. The Cochrane Collaboration, 2007.
123. Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD002831.pub2]
124. Zautra AJ. Life events and demoralization in the elderly. Grant proposal - Department of Psychology, Arizona State University; Tempe, AZ 1984.
125. Zautra AJ, Guarnaccia CA, Reich JW. The factor structure of mental health measures for older adults. Journal of Consulting and Clinical Psychology 1988;56:514-9.